img post thumbnail url
July 20, 2020 - Posted by

As a distributor of laboratory autoclave sterilizers, which can be used for decontamination of biowaste to prevent disposal  biohazardous material, we have been closely monitoring developments with the 2019 novel coronavirus (2019-nCoV / SARS-CoV-2), also known as COVID-19.

Handling, processing and disposal of waste thought to be infected with coronavirus (2019-nCoV / SARS-CoV-2), including but not limited to coronavirus (COVID-19) Real-Time PCR assays (testing kits) requires strict adherence to laboratory biosafety protocol as outlined by organizations including the WHO (World Health Organization), CDC (Center for Disease Control) and OSHA (Occupational Safety and Health Administration).

Please find select information and resources on laboratory biosafety related to the proper sterilization and disposal of waste containing coronavirus (2019-nCoV / SARS-CoV-2) specimens, PCR Assays (testing kits) and other disposable items used in coronavirus (COVID-19) laboratory research and testing.

Autoclaves and Safe Disposal of Biohazardous

As outlined in numerous guidelines covering the safe disposal of biohazardous, the use of autoclave sterilizers to deactivate pathogens and decontaminate potentially infectious waste prior to disposal is integral in preventing the spread of disease to laboratory workers, waste management personnel and the general public.

The importance of biowaste sterilization is reflected in the core facility design requirements in the WHO’s Laboratory biosafety guidance related to the novel coronavirus (2019-nCoV), which states that “appropriate methods for decontamination of waste, for example disinfectants and autoclaves, must be available in proximity to the laboratory.”¹

As a fundamental objective of biosafety programs to contain potentially harmful pathogens, in the CDC’s Biosafety in Microbiological and Biomedical Laboratories, it is recommended that laboratories of all BSLs (biosafety levels) not only create secondary barriers which include separating laboratory work areas from public access, making available decontamination facilities (e.g., autoclave), and hand washing facilities.²

Novel Coronavirus (SARS-CoV-2) is classified BSL 2, for which autoclave sterilization is recommended for any waste potentially containing it.

Novel Coronavirus (SARS-CoV-2) is classified BSL 2, for which numerous authoritative sources include autoclave sterilization as a requirement prior to disposal for laboratory waste potentially containing it.  Source: NIH NIAID

Managing Waste Associated with Coronavirus (COVID-19)

For laboratories handling specimens potentially containing coronavirus (2019-nCoV / SARS-CoV-2), one of the most critical biosafety tasks is managing waste that includes but not limited to real-time PCR assays (test kits) and other disposables including gloves, pipette tips, and vessels containing specimens.  Noting the principle that all samples should be handled as if they are infectious³, following the proper biosafety precautions includes the decontamination of all waste that has come into contact with all specimens prior to disposal.

At Biosafety Level (BSL) 2, the advised level for handling and processing of COVID-19 test specimens potentially containing coronavirus (2019-nCoV / SARS-CoV-2)⁴, numerous sources cite the use of autoclaves and other decontamination methods to treat bio waste before disposal.

In Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) the CDC instructs “handle laboratory waste from testing suspected or confirmed COVID-19 patient specimens as all other biohazardous waste in the laboratory.”⁵  According to CDC BSL 2 guidelines, all laboratory waste, including all cultures, stocks and other potentially infectious materials should be treated via autoclave, chemical disinfection, incineration, or other validated decontamination method before disposal.⁶

In some cases, guidelines explicitly endorse the use of autoclaves to treat laboratory waste before disposal, including the U.S. Department of Labor’s OSHA, which clearly states on its COVID-19 safety guideline page to “use an autoclave to inactivate infectious material in all waste prior to disposal.”⁷

Autoclaves for Biosafety in Waste Management

As outlined, numerous guidelines endorse the use of autoclaves to inactivate potentially infectious laboratory waste prior to disposal, as part of creating secondary barriers that prevent infectious disease from spreading to laboratory workers, waste management personnel and the general public.  When moving to a higher BSL, the proximity of autoclaves moves from within the facility, to within the laboratory to being a double-door pass through autoclave adjacent to a Class III biological safety cabinet.⁸

This positive relationship between higher safety needs and the proximity of the autoclave may suggest that the closer an autoclave is to the area in which potentially infectious pathogens are being handled, the safer it is in preventing the potential spread of the virus within and outside the laboratory and potentially infecting countless individuals.

Laboratories in immediate need of a primary or secondary autoclave may be interested in learning about TOMY top-loading autoclaves.  Due to their compact size, portability, setup that requires no installation and ability to operate anywhere in proximity to a source of power, they can be placed next to a biosafety cabinet or at the end of a workbench in any laboratory.

For information on features, pricing, and availability, please email, call 858-800-3900 or use the contact form below to contact an autoclave expert.

Tomy SX-Series Autoclave Sterilizer

Saves You Lots

Disclaimer: TOMY autoclaves for research use only.  Information contained in this blog entry is not meant to substitute proper research, execution and maintenance of laboratory biosafety practices.  Please check most up-to-date information from authoritative sources for laboratory biosafety and adhere to applicable federal, state and local biosafety regulations.


² p.23
³PrimerdesignTM Ltd Coronavirus (COVID-19) genesig® Real-Time PCR assay Instructions for Use (IFU)
⁴Frequently Asked Questions about Laboratory Biosafety and SARS-CoV-2
⁵Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)
⁶Based on CDC Biosafety Level 2 guidelines concerning Laboratory Facilities (Secondary Barriers) which states that “A method for decontaminating all laboratory wastes should be available in the facility (e.g., autoclave, chemical disinfection, incineration, or other validated decontamination method).” Biosafety in Microbiological and Biomedical Laboratories 5th Edition p.38
⁷U.S. Department of Labor OSHA Covid-19 Informational page.
⁸From autoclave use in BSL 2, BSL 3 and BSL 4 guidelines.  CDC Biosafety in Microbiological and Biomedical Laboratories 5th Edition

Our Location


  • Kebon Jeruk Business Park Blok F2-5, Jl. Raya Meruya Ilir No.88, Meruya Utara, Jakarta Barat - 11620


  • CBD Jababeka Blok A-8 Jl. Niaga Raya Kav. AA3, Jababeka II Pasar Sari


  • Japfa Indoland Center, Japfa Tower II Lt. 8/810 Jl. Panglima Sudirman No. 66-68, Surabaya 60271


  • Regus Forum Nine, 9th Floor Jl. Imam Bonjol No 9, Medan 20112

Get In Touch with Us

  • This field is for validation purposes and should be left unchanged.